Materials And Products Tenders

Open House Medicinal Department Treaties for the Active Ingredient Diclofenac, Topical Dosage Forms, Atc D11ax18

Open House Pharmaceutical Discounts on the Active Ingredient Enalapril, Atc C09aa02

Open House Pharmaceutical Discounts on the Active Ingredient Oxycodon and Naloxone, Atc N02aa55

Open House Pharmaceutical Discount Contracts to the Active Ingredient Riskizumab, Atc L04ac18

Open House Pharmaceutical Discounts on the Active Ingredient Dolutegravir, Atc J05aj03

Open House Pharmaceutical Discounts on the Active Ingredient Clindamycin and Benzoylperoxide, Atc D10af54

Completion of Non-Exclusive Discount Agreements According to § 130 a (8) Sgb V with the Active Ingredient Epoetin Zeta

No Discharge

Open House Biologika Discount Contracts 2025-15

Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Liraglutid (ATC-Code nach WHO: A10BJ02; amtlicher ATC: A10BJ02)